Delivery Order SPE2DB22D3102-SPE2DB25FL2XB
- Not listed
- The Defense Logistics Agency awarded a $2,079.91 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under a larger contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lidocaine 5% Patch 30S with a ceiling value of $10,877.33. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $1,622.36, represents a non-competitive set-aside contract and is scheduled for completion by August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. This...
- The Defense Logistics Agency awarded a $6.86K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lidocaine 5% Patch 30s, with final delivery due by September 9, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $4,131.60 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 3, 2025. This contract reflects a firm fixed price arrangement with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $2,761.61 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed and delivered from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $2,170.58. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and was awarded without a set-aside designation through competitive procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,160.34 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30-count units, valued at $1,134.20. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2XBDelivery Order
The Defense Logistics Agency awarded a $2,722.08 delivery order to AmerisourceBergen Drug Corp for 30 units of Lidocaine 5% Patch on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply requirements across multiple therapeutic domains, positioning the company as a critical vendor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/9/25 |